Admission serum magnesium level does not predict the hospital outcome of patients with acute myocardial infarction.

@article{Madias1996AdmissionSM,
  title={Admission serum magnesium level does not predict the hospital outcome of patients with acute myocardial infarction.},
  author={John E. Madias and Kirtikant Sheth and Muneeb A. Choudry and D O Berger and Nicolaos E. Madias},
  journal={Archives of internal medicine},
  year={1996},
  volume={156 15},
  pages={1701-8}
}
OBJECTIVE To establish whether hypomagnesemia at admission predicts excessive morbidity, particularly cardiac arrhythmias, and mortality in patients with acute myocardial infarction. METHODS We compared hypomagnesemic and normomagnesemic patients with acute myocardial infarction in 517 patients admitted to the coronary care unit. The serum magnesium concentration, along with a large array of other parameters, was measured on admission to the emergency department. Other baseline attributes and… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
No difference was detected between the hypomagnesemic and normomagnesemic cohorts in rates of total mortality ( 18.9% vs 18.5% , P = .91 ) , cardiac mortality ( 15.2% vs 15.3% , P = .99 ) , atrial fibrillation ( 13.6% vs 13.8% , P = .97 ) , ventricular tachycardia ( 18.2% vs 15.3% , P = .44 ) , or ventricular fibrillation ( 15.2% vs 13.5% , P = .63 ) .
No difference was detected between the hypomagnesemic and normomagnesemic cohorts in rates of total mortality ( 18.9% vs 18.5% , P = .91 ) , cardiac mortality ( 15.2% vs 15.3% , P = .99 ) , atrial fibrillation ( 13.6% vs 13.8% , P = .97 ) , ventricular tachycardia ( 18.2% vs 15.3% , P = .44 ) , or ventricular fibrillation ( 15.2% vs 13.5% , P = .63 ) .
No difference was detected between the hypomagnesemic and normomagnesemic cohorts in rates of total mortality ( 18.9% vs 18.5% , P = .91 ) , cardiac mortality ( 15.2% vs 15.3% , P = .99 ) , atrial fibrillation ( 13.6% vs 13.8% , P = .97 ) , ventricular tachycardia ( 18.2% vs 15.3% , P = .44 ) , or ventricular fibrillation ( 15.2% vs 13.5% , P = .63 ) .
No difference was detected between the hypomagnesemic and normomagnesemic cohorts in rates of total mortality ( 18.9% vs 18.5% , P = .91 ) , cardiac mortality ( 15.2% vs 15.3% , P = .99 ) , atrial fibrillation ( 13.6% vs 13.8% , P = .97 ) , ventricular tachycardia ( 18.2% vs 15.3% , P = .44 ) , or ventricular fibrillation ( 15.2% vs 13.5% , P = .63 ) .
No difference was detected between the hypomagnesemic and normomagnesemic cohorts in rates of total mortality ( 18.9% vs 18.5% , P = .91 ) , cardiac mortality ( 15.2% vs 15.3% , P = .99 ) , atrial fibrillation ( 13.6% vs 13.8% , P = .97 ) , ventricular tachycardia ( 18.2% vs 15.3% , P = .44 ) , or ventricular fibrillation ( 15.2% vs 13.5% , P = .63 ) .
No difference was detected between the hypomagnesemic and normomagnesemic cohorts in rates of total mortality ( 18.9% vs 18.5% , P = .91 ) , cardiac mortality ( 15.2% vs 15.3% , P = .99 ) , atrial fibrillation ( 13.6% vs 13.8% , P = .97 ) , ventricular tachycardia ( 18.2% vs 15.3% , P = .44 ) , or ventricular fibrillation ( 15.2% vs 13.5% , P = .63 ) .
No difference was detected between the hypomagnesemic and normomagnesemic cohorts in rates of total mortality ( 18.9% vs 18.5% , P = .91 ) , cardiac mortality ( 15.2% vs 15.3% , P = .99 ) , atrial fibrillation ( 13.6% vs 13.8% , P = .97 ) , ventricular tachycardia ( 18.2% vs 15.3% , P = .44 ) , or ventricular fibrillation ( 15.2% vs 13.5% , P = .63 ) .
No difference was detected between the hypomagnesemic and normomagnesemic cohorts in rates of total mortality ( 18.9% vs 18.5% , P = .91 ) , cardiac mortality ( 15.2% vs 15.3% , P = .99 ) , atrial fibrillation ( 13.6% vs 13.8% , P = .97 ) , ventricular tachycardia ( 18.2% vs 15.3% , P = .44 ) , or ventricular fibrillation ( 15.2% vs 13.5% , P = .63 ) .
All Topics